Showing results (851-860 of 870) with videos related to
Sort By:
Pageof 87
Cancer Cell|July 14, 2012
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastomaTeeara Berry, William Luther, Namrata Bhatnagar, et al.Nature Communications|December 17, 2024
Imaging NRF2 activation in non-small cell lung cancer with positron emission tomographyHannah E Greenwood, Abigail R Barber, Richard S Edwards, et al.Nature Communications|December 22, 2019
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumorAndrew J Murphy, Xiang Chen, Emilia M Pinto, et al.Science Advances|March 15, 2024
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressivenessXiaodan Qin, Andrew Lam, Xu Zhang, et al.Transfusion|July 11, 2025
ABO-mismatched platelet and plasma transfusion practices and the potential for transfusion-related alpha-gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative StudyNancy M Dunbar, Richard M Kaufman, Karina S Bary, et al.Nature Cancer|September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypesSatyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.Cancer Cell|December 10, 2014
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitorCamilla L Christensen, Nicholas Kwiatkowski, Brian J Abraham, et al.Nature Communications|July 27, 2019
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastomaMatthew Wong, Yuting Sun, Zhichao Xi, et al.Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug AdministrationAndrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.Pageof 87